ReviewCancer drug resistance (Alhambra, Calif.)2026

A systematic review and network meta analysis of first-line immunotherapy for advanced urothelial carcinoma.

Yang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.